Manufacture of certain products for sale outside of Minnesota provided, tetrahydrocannabivarin designated as a nonintoxicating cannabinoid, potency limits modified, social equity ownership requirements lowered to 51 percent, manufacturing limits established, and cannabis cultivator license authorizations clarified.
Omnibus Cannabis Policy Bill
Medical cannabis combination business plant canopy increase to cultivate cannabis sold as medical cannabis flower or medical cannabinoid products provision
Provisions modification regarding the sale of cannabinoids derived from hemp
Provisions regarding the sale of cannabinoids derived from hemp modified, person selling edible cannabinoids permitted to convert the person's registration to a comparable hemp license, and hemp-derived topical product provisions modified.
Various cannabis provisions modifications
Medical cannabis and cannabis provisions modified.